ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Proteases >HCV Protease Inhibitors >Daclatasvir

Daclatasvir

CAS No.: 1009119-64-5

Chemical Name:: Daclatasvir

Synonyms: EBP 883;CS-1933;Daklinza;daclatavir;aclatasvir;Dacaltasvir;Daclatasvir;Dhaka He Wei;Daclatasvir-d16;Daclatasvir/EBP883

CBNumber:: CB52515028

Molecular Formula:: C40H50N8O6

Molecular Weight:: 738.88

MOL File:: 1009119-64-5.mol

Modify Date:: 2024/3/22 21:24:34

Request For Quotation

Daclatasvir Properties

Melting point	>155oC (dec.)
Boiling point	1071.2±65.0 °C(Predicted)
Density	1.249
storage temp.	Refrigerator
solubility	Aqueous Acid (Slightly), Chloroform (Sparingly), DMSO (Sparingly), Methanol (Sparingly)
form	Solid
pka	10.92±0.46(Predicted)
color	White to Dark Yellow

SAFETY

Risk and Safety Statements

Symbol(GHS)

GHS07

Signal word

Warning

Hazard statements

H302

Precautionary statements

P264-P270-P301+P312-P330-P501

Safety Statements

24/25

HS Code

29332900

NFPA 704

	0
2		0

Daclatasvir Chemical Properties,Uses,Production

Uses

Daclatasvir, inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV).

Definition

ChEBI: A member of the class of biphenyls that is a potent inhibitor of nonstructural protein 5A and is used (as its hydrochloride salt) for treatment of hepatitis C.

Daclatasvir Preparation Products And Raw materials

Raw materials

Preparation Products

Daclatasvir Suppliers

Global( 243)Suppliers

Supplier	Tel	Country	ProdList	Advantage	Inquiry
Varanous Labs Pvt Ltd	+91-7036248882 +91-7036248882	Hyderabad, India	1541	58	Inquiry
Aspen Biopharma Labs Pvt Ltd	+91-9248058660 +91-9248058662	Telangana, India	234	58	Inquiry
BDR Pharmaceuticals International Pvt Ltd	+91-2240560560 +91-7718884418	Maharashtra, India	206	58	Inquiry
CLEARSYNTH LABS LTD.	+91-22-45045900	Hyderabad, India	6351	58	Inquiry
SynZeal Research Pvt Ltd	+1 226-802-2078	Gujarat, India	6522	58	Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd	+91-172-5066494	Haryana, India	6773	58	Inquiry
Deep Healthcare Enterprises	08048979503	Delhi, India	2	58	Inquiry
Triveni Interchem Private Limited (Group Of Triveni...	08046042087	Gujarat, India	497	58	Inquiry
Clearsynth Labs	91-22-45045900	Maharashtra, India	3889	58	Inquiry
Viruj Pharmaceuticals Pvt. Ltd.	91-40-23070010	Hyderabad, India	13	58	Inquiry

Supplier	Advantage
Varanous Labs Pvt Ltd	58
Aspen Biopharma Labs Pvt Ltd	58
BDR Pharmaceuticals International Pvt Ltd	58
CLEARSYNTH LABS LTD.	58
SynZeal Research Pvt Ltd	58
Pharmaffiliates Analytics and Synthetics P. Ltd	58
Deep Healthcare Enterprises	58
Triveni Interchem Private Limited (Group Of Triveni...	58
Clearsynth Labs	58
Viruj Pharmaceuticals Pvt. Ltd.	58

Daclatasvir Spectrum

Daclatasvir(1009119-64-5)¹HNMR

1009119-64-5(Daclatasvir)Related Search:

Tenofovir Daclatasvir Impurity 4 Daclatasvir Impurity D Daclatasvir Impurity 7 (RRRR-Isomer) Tenofovir disoproxil fumarate

4,4'-Bis(2-bromoacetyl)biphenyl 1-Pyrrolidinecarboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)- Dasatinib Lapatinib 4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzonitrile

Telaprevir Sunitinib Malate Ribavirin Sofosbuvir PLX4032

chevron_left

1of3

chevron_right

diMethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl) Daclatasvir EBP 883 N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate Daclatasvir/EBP883 daclatavir DiMethyl (2S, 2'S)-1, 1'-((2S, 2'S)-2, 2'-(4, 4'-(biphenyl-4, 4'-diyl)bis(1H-iMidazole-4, 2-diyl))bis(pyrrolidine-2, 1-diyl))bis(3-Methyl-1-oxobutane-2, 1-diyl)dicarbaMate (Related Reference) Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester Daclatasvir BMS 790052 Dacaltasvir Daklinza Daclatasvir-d16 Dhaka He Wei BMS-790052(Daclatasvir) Daclatasvir, >=98% Dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl)) BMS-790052;EBP 883;BMS 790052 CS-1933 Daclatasvir, 99%, Highly selective HCV NS5A inhibitors dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-d dimethyl(2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazolChemicalbooke-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate Daclatasvir 13C2D6Q: What is Daclatasvir 13C2D6 Q: What is the CAS Number of Daclatasvir 13C2D6 Q: What is the storage condition of Daclatasvir 13C2D6 Q: What are the applications of Daclatasvir 13C2D6 DaclatasvirQ: What is Daclatasvir Q: What is the CAS Number of Daclatasvir Q: What is the storage condition of Daclatasvir C40H50N8O6 Daclatasvir (BMS-790052) 1009119-64-5 Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate aclatasvir Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate 1009119-64-5 1009119-94-5 C40H50N8O6 C41H52N8O6 API Inhibitors